Baillie Gifford & Co’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,711
| Closed | -$1.34K | – | 459 |
|
|
2023
Q1 | $1.34K | Hold |
3,711
| – | – | ﹤0.01% | 440 |
|
|
2022
Q4 | $3.29K | Hold |
3,711
| – | – | ﹤0.01% | 463 |
|
|
2022
Q3 | $6K | Sell |
3,711
-603
| -14% | -$975 | ﹤0.01% | 441 |
|
|
2022
Q2 | $9K | Hold |
4,314
| – | – | ﹤0.01% | 427 |
|
|
2022
Q1 | $10K | Hold |
4,314
| – | – | ﹤0.01% | 438 |
|
|
2021
Q4 | $20K | Hold |
4,314
| – | – | ﹤0.01% | 380 |
|
|
2021
Q3 | $33K | Sell |
4,314
-838
| -16% | -$6.41K | ﹤0.01% | 313 |
|
|
2021
Q2 | $50K | Sell |
5,152
-379
| -7% | -$3.68K | ﹤0.01% | 288 |
|
|
2021
Q1 | $46K | Buy |
5,531
+422
| +8% | +$3.51K | ﹤0.01% | 280 |
|
|
2020
Q4 | $35K | Buy |
+5,109
| New | +$35K | ﹤0.01% | 285 |
|